Welcome to our dedicated page for BNBX news (Ticker: BNBX), a resource for investors and traders seeking the latest updates and insights on BNBX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BNBX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BNBX's position in the market.
Applied DNA Sciences (NASDAQ: BNBX) closed a private placement (PIPE) on October 22, 2025, generating approximately $27.0 million gross proceeds with the potential for up to an additional $31 million from future warrant exercises. Gross proceeds included $15.3 million in cash and stablecoins and $11.71 million in OBNB trust units.
The company received 435,638 trust units representing underlying ownership of 10,647 BNB tokens and separately purchased an additional 4,908 BNB tokens (~$5.3M as of Oct 20, 2025). Prefunded warrants and related warrants are not exercisable until stockholder approval. Applied DNA also reported streamlining actions yielding approximately $2.9M in annualized cost savings and intends to use proceeds to implement its BNB treasury strategy and support working capital.
